Comparative genomic hybridization detects frequent overrepresentation of chromosomal material from 3q26, 8q24, and 20q 13 in human ovarian carcinomas

Genes Chromosomes and Cancer

Volumn 20, Issue 4, 1997, Pages 320-328

  Sonoda, Gonosuke ^a   Palazzo, Juan ^b   Du Manoir, Stanislas ^c   Godwin, Andrew K ^a   Feder, Madelyn ^a   Yakushiji, Michiaki ^d   Testa, Joseph R ^a  

^a FOX CHASE CANCER CENTER   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^d KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHROMOSOME 20Q; CHROMOSOME 3Q; CHROMOSOME 8Q; CHROMOSOME ABERRATION; CHROMOSOME NOR; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GENE AMPLIFICATION; HUMAN; HUMAN TISSUE; HYBRIDIZATION; IMAGE ANALYSIS; ONCOGENE; OVARY CARCINOMA; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ADULT; AGED; AGED, 80 AND OVER; CHROMOSOME ABERRATIONS; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 20; CHROMOSOMES, HUMAN, PAIR 3; CHROMOSOMES, HUMAN, PAIR 8; DNA, NEOPLASM; FEMALE; GENE AMPLIFICATION; GENE DOSAGE; HUMANS; MIDDLE AGED; NUCLEIC ACID HYBRIDIZATION; OVARIAN NEOPLASMS;

EID: 0030715586     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(199712)20:4<320::AID-GCC2>3.0.CO;2-3     Document Type: Article

References (52)

1. Arnold N, Hägele L, Walz L, Schempp W, Pfisterer J, Bauknecht T, Kiechle M (1996) Overrepresentation of 3q and 8p material and loss of 18q material are recurrent findings in advanced human ovarian cancer. Genes Chromosomes Cancer 16:46-54.
2. Bellacosa A, De Feo D, Godwin AK, Bell DW, Cheng JQ, Altomare DA, Wan M, Dubeau L, Scambia G, Masciullo V, Ferrandina G, Benedetti Panici P, Mancuso S, Neri G, Testa JR (1995) Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas. Int J Cancer 64:280-285.
3. Bello MJ, Rev JA (1990) Chromosome aberrations in metastatic ovarian cancer: Relationship with abnormalities in primary tumors. Int J Cancer 45:50-54.
4. Berchuck A (1995) Biomarkers in the ovary. J Cell Biol 23:223-226.
5. Brzoska PM, Levin NA, Fu KK, Kaplan MJ, Singer MI, Gray JW, Christman MF (1995) Frequent novel DNA copy number increase in squamous cell head and neck tumors. Cancer Res 55:3055-3059.
6. Cheng JQ, Godwin AK, Bellacosa A, Taguchi T, Franke TF, Hamilton TC, Tsichlis PN, Testa JR (1992) AKT2, a putative oncogene encoding a member of a novel subfamily of serinethreonine protein kinases, is amplified in human ovarian carcinomas. Proc Natl Acad Sci USA 89:9267-9271.
7. du Manoir S, Speicher MR, Joos S, Schröck E, Popp S, Döhner H, Kovacs G, Robert-Nicoud M, Lichter P, Cremer T (1993) Detection of complete and partial chromosome gains and losses by comparative genomic in situ hybridization. Hum Genet 90:590-610.
8. du Manoir S, Schröck E, Bentz M, Speicher MR, Joos S, Ried T, Lichter P, Cremer T (1995) Quantitative analysis of comparative genomic hybridization. Cytometry 19:27-41.
9. Ehlen T, Dubeau L (1990) Loss of heterozygosity on chromosomal segments 3p, 6q and 11p in human ovarian carcinomas. Oncogene 5:219-223.
10. Filmus J, Buick RN (1485) Stability of c-K-ras amplification during progression in a patient with adenocarcinoma of the ovary. Cancer Res 45:4468-4472.
11. Foulkes WD, Ragoussis J, Stamp GWH, Allan GJ, Trowsdale J (1993) Frequent loss of heterozygosity on chromosome 6 in human ovarian carcinoma. Br J Cancer 67:551-559.
12. Fukumoto M, Estensen RD, Sha L, Oakley GJ, Twiggs LB, Adcock LL, Carson LF, Roninson IB (1989) Association of Ki-ras with amplified DNA sequences, detected in human ovarian carcinomas by a modified in-gel renaturation assay. Cancer Res 49:1693-1697.
13. Gershenson DM, Tortolero-Luna G, Malpica A, Baker VV, Whittaker L, Johnson E, Follen Mitchell M (1996) Ovarian intraepithelial neoplasia and ovarian cancer. Obstet Gynecol Clin North Am 23:475-543.
14. Gordon KB, Thompson CT, Char DH, O'Brien JM, Kroll S, Ghazvini S, Gray JW (1994) Comparative genomic hybridization in the detection of DNA copy number abnormalities in uveal melanoma. Chancer Res 54:4764-4768.
15. Gray J, Daneshvar I, Shoenberg-Fejzo M, Hwang S, Godfrey T, Palazzolo Martin C, Kowbel D, Tanner M, Kallionemi OP, Rommens J, Pinkel D, Collins C (1997) Genomic analysis of three regions of increased copy number discovered using CGH. Seventh Internarional Workshop on Chromosomes in Solid Tumors, Tucson, AZ.
16. Guan X-Y, Cargile CB, Anzick SL, Thompson FH, Meltzer PS, Bittner ML, Taetle R, McGill JR, Trent JM (1995) Chromosome microdissection identifies cryptic sites of DNA sequence amplification in human ovarian carcinoma. Cancer Res 55:3380-3385.
17. Heim S, Mitelman F (1995) Cancer Cytogenetics. 2nd ed. New York: Wiley-Liss, Inc.
18. Heselmeyer K, Schröck E, du Manoir S, Blegen H, Shah K, Steinbeck R, Auer G, Ried T (1996) Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix. Proc Natl Acad Sci USA 93:479-484.
19. Iwabuchi H, Sakamoto M, Sakunaga H, Ma Y-Y, Carcangiu ML, Pinkel D, Yang-Feng TL, Gray JW (1995) Genetic analysis of benign, low-grade, and high-grade ovarian tumors. Cancer Res 55:6172-6180.
20. Kallioniemi A, Kallioniemi O-P, Sudar D, Rutovitz D, Gray JW, Waldman F, Pinkel D (1992) Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258:818-821.
21. Kapeller R, Cantley LC (1994) Phosphatidylinositol 3-kinase. Bioessays 16:565-576.
22. Lee JH, Kavanagh JJ, Wildrick DM, Wharton JT, Blick M (1990) Frequent loss of heterozygosity on chromosomes 6q, 11, and 17 in human ovarian carcinomas. Cancer Res 50:2724-2728.
23. Levin NA, Brzoska P, Gupta N, Minna JD, Gray JW, Christman MF (1994) Identification of frequent novel genetic alterations in small cell lung carcinoma. Cancer Res 54:5086-5091.
24. Liang BC, Meltzer PS, Guan X-Y, Trent JM (1995) Gene amplification elucidated by combined chromosomal microdissection and comparative genomic hybridization. Cancer Genet Cytogenet 80:55-95.
25. Merajver SD, Pham TM, Caduff RF, Chen M, Poy EL, Cooney KA, Weber BL, Collins FS, Johnston C, Frank TS (1995) Somatic mutations in the BRCA1 gene in sporadic ovarian tumours. Nature Genet 9:439-443.
26. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran, C, Bennett LM, Ding W, Bell R, Rosenthal J, Hussey C, Tran T, McClure M, Frye C, Hattier T, Phelps R, Haugen-Strano A, Karcher H, Yakumo K, Gholami Z, Shaffer D, Stone S, Bayer S, Wray C, Bogden R, Dayananth P, Ward J, Tonin P, Narod S, Bristow PK, Norris FH, Helvering L, Morrison P, Rosteck P, Lai M, Barrett JC, Lewis C, Neuhausen S, Cannon-Albright L, Goldgar D, Wiseman R, Kamb A, Skolnick MH (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66-71.
27. Mok SC, Kwok TT, Berkowitz RS, Barrett AJ, Tsui FW (1995) Overexpression of the protein tyrosine phosphatase, nonreceptor type 6 (PTPN6), in human epithelial ovarian cancer. Gynecol Oncol 57:299-303.
28. Panani A, Ferti-Passantonopoulou A (1985) Common marker chromosomes in ovarian cancer. Cancer Genet Cytogenet 16:65-71.
29. Parker SL, Tong T, Bolden S, Wingo PA (1996) Cancer statistics 1996. CA Cancer J Clin 65:5-27.
30. Pejovic T, Heim S, Mandahl N, Baldetorp B, Elmfors B, Floderus U-M, Furgyik S, Heim G, Himmelmann A, Willen H, Mitelman F (1992) Chromosome aberrations in 35 primary ovarian carcinomas. Genes Chromosomes Cancer 4:58-68.
31. Ried T, Knutzen R, Steinbeck R, Biegen H, Schöck E, Heselmeyer K, du Manoir S, Auer G (1996) Comparative genomic hybridization reveals a specific pattern of chromosomal gains and losses during the genesis of colorectal tumors. Genes Chromosomes Cancer 15:234-245.
32. Sambrook J, Fritsch EF, Maniatis T (1989) Molecular Cloning. A Laboratory Manual. 2nd ed. Plainview, NY: Cold Spring Harbor Laboratory Press.
33. Sato T, Saito H, Morita R, Koi S, Lee JH, Nakamura Y (1991) Allelotype of human ovarian cancer. Cancer Res 51:5118-5122.
34. Schreiber G, Dubeau L (1990) C-myc proto-oncogene amplification detected by polymerase chain reaction in archival human ovarian carcinomas. Am J Pathol 137:653-658.
35. Schultz DC, Vanderveer L, Buetow KH, Boente MP, Ozols RF, Hamilton TC, Godwin AK (1995) Characterization of chromosome 9 in human ovarian neoplasia identifies frequent genetic imbalance on 9q and rare alterations involving 9p, including CDKN2. Cancer Res 55:2150-2157.
36. Simard J, Tonin P, Durocher F, Morgan K, Romments J, Gingras S, Samson C, Leblanc J-F, Bélanger C, Dion F, Lin Q, Skolnick M, Goldgar D, Shattuck-Eidens D, Labrie F, Narod SA (1994) Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families. Nature Genet 8:392-398.
37. Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A, Press MF (1989) Studies of the HER-2neu proto-oncogene in human breast and ovarian cancer. Science 244:707-712.
38. Sonoda G, du Manoir S, Godwin AK, Bell DW, Liu Z., Hogan M, Yakushiji M, Testa JR (1997) Detection of DNA gains and losses in primary endometrial carcinomas by comparative genomic hybridization. Genes Chromosomes Cancer 18:115-125.
39. Speicher MR, Howe C, Crotty P, du Manoir S, Costa J, Ward DC (1995) Comparative genomic hybridization detects novel deletions and amplifications in head and neck squamous cell carcinomas. Cancer Res 55:1010-1013.
40. Takahashi H, Behbakht K, McGovern PE, Chin H-C, Couch FJ, Weber BL, Friedman LS, King M-C, Furusato M, LiVolsi VA, Menzin AW, Liu PC, Benjamin I, Morgan MA, King SA, Rebane BA, Cardonick A, Mikuta JJ, Rubin SC, Boyd J (1995) Mutation analysis of the BRCA1 gene in ovarian cancers. Cancer Res 55:2998-3002.
41. Tanaka K, Boice CR, Testa JR (1989) Chromosome aberrations in nine patients with ovarian cancer. Cancer Genet Cytogenet 43:1-14.
42. Tanner MM, Tirkkonen M, Kallioniemi A, Collins C, Stokke T, Karhu R, Kowbel D, Shadravan F, Hintz M, Kuo W-L, Waldman FM, Isora JJ, Gray JW (1994) Increased copy number at 20q13 in breast cancer: defining the critical region and exclusion of candidate genes. Cancer Res 54:4257-4260.
43. Tanner MM, Tirkkonen M, Kallioniemi A, Isola J, Kuukasjarvi T, Collins C, Kowbel D, Guan XY, Trent J, Gray JW, Meltzer P (1996) Independent amplification and frequent co-amplification of three nonsyntenic regions on the long arm of chromosome 20 in human breast cancer. Cancer Res 56:3441-3445.
44. Tarkkanen M, Karhu R, Kallioniemi A, Elomaa I, Kivioja AH, Nevalainen J, Böhling T, Karaharju E, Hyytinen F, Knuutila S, Kallioniemi O-P (1995) Gains and losses of DNA sequences in osteosarcomas by comparative genomic hybridization. Cancer Res 55:1334-1338.
45. Tavassoli M, Steingrimsdottir H, Pierce E, Jiang X, Alagoz M, Farzaneh F, Campbell IG (1996) Loss of heterozygosity on chromosome 5q in ovarian cancer is frequently accompanied by TP53 mutation and identifies a tumour suppressor gene locus at 5q13.1-21. Br J Cancer 74:115-119.
46. Trent JM, Salmon SF (1981) Karyotypic analysis of human ovarian carcinoma cells cloned in short term agar culture. Cancer Genet Cytogenet 3:279-291.
47. Visakorpi T, Kallioniemi AH, Syvänen A-C, Hyytinen ER, Karhu R, Tammela T, Isola JJ, Kallioniemi G-P (1995) Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization. Cancer Res 55:342-347.
48. Wake N, Hreshchyshyn MM, Piver SM, Matsui S, Sandberg AA (1980) Specific cytogenetic changes in ovarian cancer involving chromosomes 6 and 14. Cancer Res 40:4512-4518.
49. Whang-Peng J, Knutsen T, Douglass EC, Chu E, Ozols RF, Hogan WM, Young RC (1984) Cytogenetic studies in ovarian cancer. Cancer Genet Cytogenet 11:91-106.
50. Yang-Feng TL, Han H, Chen KC, Li S, Claus EB, Carcangiu ML, Chambers SK, Chambers JT, Schwartz PE (1993) Allelic loss in ovarian cancer. Int J Cancer 54:546-551.
51. Yokota J, Tsunetsugu-Yokota Y, Battifora H, Le Fevre C, Cline MJ (1986) Alterations of myc, myb, and ras proto-oncogenes in cancers are frequent and show clinical correlation. Science 231:261-265.
52. Zheng J, Robinson WR, Ehlen T, Yu MC, Dubeau L (1991) Distinction of low grade from high grade ovarian carcinomas on the basis of losses of heterozygosity on chromosomes 3, 6 and 11 and HER-2/neu gene amplification. Cancer Res 51:4045-4051.